skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis of optically pure dioxolane nucleosides and their anti-HIV activity

Conference ·
OSTI ID:141130
; ; ; ; ; ;  [1];  [2]
  1. BioChem Parma Inc., Quebec (Canada)
  2. Glaxo Group Research Ltd., Greenford (United Kingdom)

The clinical candidate 3TC, 1, possessing non-natural absolute stereochemistry is a potent and non-toxic inhibitor of a key enzyme, reverse transcriptase, involved in the replicative cycle of the HIV. Selective inhibition of both HIV and HBV is seen. In view of the authors` interest in finding correlation between stereochemistry and antiviral activity, several enantiomerically pure dioxolane nucleosides, 2, were synthesized and assayed. The discussion will focus on (a) the synthesis of optically pure dioxolane sugars from L-ascorbic acid, (b) enzymatic resolution of purine dioxolane nucleosides, (c) anti HIV-1 activity in MT-4 cells.

OSTI ID:
141130
Report Number(s):
CONF-930304-; TRN: 93:003688-0805
Resource Relation:
Conference: 205. American Chemical Society national meeting, Denver, CO (United States), 28 Mar - 2 Apr 1993; Other Information: PBD: 1993; Related Information: Is Part Of 205th ACS national meeting; PB: 1951 p.
Country of Publication:
United States
Language:
English